Multisystem Inflammatory Syndrome in a 12-Year-old Boy After mRNA-SARS-CoV-2 Vaccination

Abobakr A Abdelgalil; Fajr A Saeedi

doi:10.1097/INF.0000000000003442

Multisystem Inflammatory Syndrome in a 12-Year-old Boy After mRNA-SARS-CoV-2 Vaccination

Pediatr Infect Dis J. 2022 Mar 1;41(3):e93-e94. doi: 10.1097/INF.0000000000003442.

Authors

Abobakr A Abdelgalil¹, Fajr A Saeedi²

Affiliations

¹ From the Department of Pediatrics, Cairo University, Cairo, Egypt.
² Department of Pediatrics, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia.

Abstract

Multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection is well known. We describe a 12-year-old child developing MIS-C after receiving 2 doses of mRNA COVID-19 vaccines without clinical evidence of COVID-19 infection. A possible association between the SARS-CoV-2 vaccine and MIS-C cannot be excluded.

Publication types

Case Reports

MeSH terms

COVID-19 / complications*
COVID-19 / diagnosis
COVID-19 / etiology
COVID-19 / prevention & control
COVID-19 Drug Treatment
COVID-19 Vaccines / adverse effects*
Child
Diagnosis, Differential
Humans
Immunoglobulins, Intravenous / therapeutic use
Male
SARS-CoV-2
Systemic Inflammatory Response Syndrome / diagnosis
Systemic Inflammatory Response Syndrome / drug therapy
Systemic Inflammatory Response Syndrome / etiology*
mRNA Vaccines / adverse effects*

Substances

COVID-19 Vaccines
Immunoglobulins, Intravenous
mRNA Vaccines

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related